Trading in CELLINK’s shares starts on Nasdaq Stockholm Main Market

CELLINK AB (publ) (“CELLINK” or the “Company”) announces today the commencement of trading in the company’s shares on Nasdaq Stockholm Main Market.

I would like to begin by thanking the entire CELLINK team, the board of directors, investors, and, above all, our customers for their continued trust and for their amazing work. This exciting journey started by four pioneers just four years ago and has now matured to a multinational company operating in six countries, with 200 brilliant employees, installations in more than 55 countries around the world, and is now listed on Nasdaq Stockholm Main Market. It is with tremendous pride, honor, and confidence that we look into the future entering into a new chapter for CELLINK, following the vision of changing the future of medicine as we know it.”

Erik Gatenholm, CEO of CELLINK

CELLINK’s shares will continue to be traded under the same ticker (CLNK B) and ISIN code (SE0013647385). No new shares will be issued in connection with the listing. Shareholders of CELLINK do not need to take any action in connection with the listing on Nasdaq Stockholm Main Market.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    CELLINK. (2020, April 22). Trading in CELLINK’s shares starts on Nasdaq Stockholm Main Market. News-Medical. Retrieved on March 23, 2023 from https://www.news-medical.net/news/20200422/Trading-in-CELLINKe28099s-shares-starts-on-Nasdaq-Stockholm-Main-Market.aspx.

  • MLA

    CELLINK. "Trading in CELLINK’s shares starts on Nasdaq Stockholm Main Market". News-Medical. 23 March 2023. <https://www.news-medical.net/news/20200422/Trading-in-CELLINKe28099s-shares-starts-on-Nasdaq-Stockholm-Main-Market.aspx>.

  • Chicago

    CELLINK. "Trading in CELLINK’s shares starts on Nasdaq Stockholm Main Market". News-Medical. https://www.news-medical.net/news/20200422/Trading-in-CELLINKe28099s-shares-starts-on-Nasdaq-Stockholm-Main-Market.aspx. (accessed March 23, 2023).

  • Harvard

    CELLINK. 2020. Trading in CELLINK’s shares starts on Nasdaq Stockholm Main Market. News-Medical, viewed 23 March 2023, https://www.news-medical.net/news/20200422/Trading-in-CELLINKe28099s-shares-starts-on-Nasdaq-Stockholm-Main-Market.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
CELLINK announces partnership with AstraZeneca to provide advanced 3D-bioprinted liver organoids